Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2009-2054PMID 20008019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The incretin system and its role in type 2 diabetes mellitus.

  2009cited by this paper
• Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans.

  2009cited by this paper
• Predictors of Incretin Concentrations in Subjects With Normal, Impaired, and Diabetic Glucose Tolerance

  2008cited by this paper
• Incretin and islet hormonal responses to fat and protein ingestion in healthy men.

  2008cited by this paper
• Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients

  2008cited by this paper
• Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

  2006cited by this paper
• Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice.

  2006cited by this paper
• Alpha cell function in health and disease: influence of glucagon-like peptide-1

  2005cited by this paper
• Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.

  2004cited by this paper
• Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?

  2004cited by this paper
• Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies.

  2004cited by this paper
• Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.

  2004cited by this paper
• Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

  2003cited by this paper
• Gastric emptying: the validity of the paracetamol absorption test adjusted for individual pharmacokinetics

  2001cited by this paper
• Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

  2001cited by this paper
• Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.

  2001cited by this paper
• The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction

  2001cited by this paper
• Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.

  2001cited by this paper
• Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

  2000cited by this paper
• Effect of obesity and major weight reduction on gastric emptying

  2000cited by this paper
• Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.

  1999cited by this paper
• Glucagon-Like Peptide-1-(7-36)Amide Is Transformed to Glucagon-Like Peptide-1-(9-36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine Intestine1.

  1999cited by this paper
• Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

  1999cited by this paper
• Attenuated GLP-1 secretion in obesity: cause or consequence?

  1996cited by this paper
• Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day.

  1996cited by this paper
• Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

  1995cited by this paper
• Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

  1994cited by this paper
• Comparison of the relationship between structure and CNS effects for lorazepam, clonazepam and alprazolam

  1993cited by this paper
• Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

  1993cited by this paper
• Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy

  1991cited by this paper

• The Gut–Brain Axis in Obesity: Mechanisms, Development, and Therapeutic Perspectives

  2026cites this paper
• Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review

  2026influential citation
• Metabolic and hormonal effects of whole grains of rye, oats and wheat in dog food

  2025cites this paper
• Preliminary evaluation of oxyntomodulin as a biomarker for metabolic risk stratification in adults with obesity

  2025influential citation
• The effect of a kibble diet versus a raw meat-based diet on energy metabolism biomarkers in dogs.

  2025cites this paper
• Recognizing overweight and obesity as chronic diseases and acknowledging root causes.

  2025cites this paper
• Treatment and Monitoring of Idiopathic Intracranial Hypertension

  2025cites this paper
• Fasting and Post Prandial Pancreatic and Enteroendocrine Hormone Levels in Obese and Non-Obese Participants

  2024cites this paper
• Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension

  2024cites this paper
• The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes

  2024cites this paper
• Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions – a narrative review

  2024cites this paper
• Caveolae with serotonin and NMDA receptors as promising targets for the treatment of Alzheimer's disease.

  2024cites this paper
• Study of post-nutrition dynamics hormone concentrations in metabolically healthy and unhealthy obese patients

  2024cites this paper
• Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases

  2024cites this paper
• Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes

  2024influential citation
• The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial

  2023cites this paper
• Weight loss by calorie restriction does not alter appetite‐regulating gut hormone responses from perfused rat small intestine

  2023cites this paper
• Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals.

  2023cites this paper
• Imbalance of Hormones Involved in Energy Balance Regulation in Obese Patients: a Study of Its Relationship with Disturbed Eating Behavior and Abnormal Metabolic Parameters

  2022cites this paper
• Title: The effect of exenatide on intracranial pressure in Idiopathic Intracranial Hypertension, IIH Pressure: A Randomised Clinical Trial

  2022cites this paper
• The effect of exenatide on intracranial pressure in Idiopathic Intracranial Hypertension, IIH Pressure: A Randomised Clinical Trial

  2022cites this paper
• Glucose‐dependent insulinotropic polypeptide secretion after oral macronutrient ingestion: The human literature revisited and a systematic study in model experiments in mice

  2022cites this paper
• Differences in gastrointestinal hormones and appetite ratings between individuals with and without obesity—A systematic review and meta‐analysis

  2022cites this paper
• Circadian secretion rhythm of GLP-1 and its influencing factors

  2022cites this paper
• Mucosal and hormonal adaptations after Roux-en-Y gastric bypass.

  2022cites this paper
• Enteroendocrine System and Gut Barrier in Metabolic Disorders

  2022cites this paper
• Impact of Obesity on Postprandial Triglyceride Contribution to Glucose Homeostasis, Assessed with a Semimechanistic Model

  2022cites this paper
• Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives

  2022cites this paper
• The Enteroendocrine System in Obesity.

  2022cites this paper
• The molecular determinants of glucagon-like peptide secretion by the intestinal L-cell.

  2022cites this paper
• The Beneficial Effect of a Healthy Dietary Pattern on Androgen Deprivation Therapy-Related Metabolic Abnormalities in Patients with Prostate Cancer: A Meta-Analysis Based on Randomized Controlled Trials and Systematic Review

  2022cites this paper
• Gastrointestinal Peptides in Eating-Related Disorders.

  2021cites this paper
• Dipeptidyl peptidase‐4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes

  2021cites this paper
• Circulating GLP-1 Levels as a Potential Indicator of Metabolic Syndrome Risk in Adult Women

  2021cites this paper
• Obesity and Dietary Added Sugar Interact to Affect Postprandial GLP-1 and Its Relationship to Striatal Responses to Food Cues and Feeding Behavior

  2021cites this paper
• Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study

  2021cites this paper
• The role of dipeptidyl peptidase-IV in abdominal aortic aneurysm pathogenesis: A systematic review

  2021cites this paper
• Feeding frequency affects the growth performance, nutrient digestion and absorption of growing pigs with the same daily feed intake

  2021cites this paper
• The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial

  2021cites this paper
• Effects of mixed meal tolerance test on gastric emptying, glucose and lipid homeostasis in obese nonhuman primates

  2021cites this paper
• Reframing appetitive reinforcement learning and reward valuation as effects mediated by hippocampal-dependent behavioral inhibition.

  2020cites this paper
• Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity.

  2020cites this paper
• Circadian Changes in Gut Peptide Levels and Obesity

  2020cites this paper
• The effect of two diets with different carbohydrate content on glucose markers in dogs

  2020cites this paper
• On Meal Effects and DPP-4 Inhibition Islet- and Incretin Hormones in Health and Type 2 Diabetes

  2020cites this paper
• Understanding the interplay between food structure, intestinal bacterial fermentation and appetite control

  2020cites this paper
• Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists

  2020cites this paper
• Small intestinal physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signaling, and gut microbiome

  2020cites this paper
• Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity

  2019cites this paper
• What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.

  2019cites this paper
• Glucagon Regulation of Energy Expenditure

  2019cites this paper
• GLP-1 Limits Adipocyte Inflammation and Its Low Circulating Pre-Operative Concentrations Predict Worse Type 2 Diabetes Remission after Bariatric Surgery in Obese Patients

  2019cites this paper
• Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes

  2019cites this paper
• GHSR‐1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin‐4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?

  2019influential citation
• Glucagon lowers glycemia when β-cells are active.

  2019cites this paper
• An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity

  2019cites this paper
• The Glucagon‐like peptide‐1 receptor agonist, exendin‐4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome

  2019cites this paper
• Neuroendocrine Regulation of Appetite and Body Weight

  2018cites this paper
• High DPP-4 Concentrations in Adolescents Are Associated With Low Intact GLP-1

  2018cites this paper
• Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function.

  2018cites this paper
• Postprandial gut hormone responses to Hass avocado meals and their association with visual analog scores in overweight adults: A randomized 3 × 3 crossover trial.

  2018cites this paper
• Incretin System: New Pharmacological Target in Obese Women with Polycystic Ovary Syndrome

  2018cites this paper
• Performance of individually measured vs population‐based C‐peptide kinetics to assess β‐cell function in the presence and absence of acute insulin resistance

  2018cites this paper
• Association between Serum Dipeptidyl Peptidase-4 Concentration and Obesity-Related Factors in Health Screen Examinees (J Obes Metab Syndr 2017;26:188–96)

  2018cites this paper
• THE IMPACT OF DEGRADATION INHIBITOR OF GLUCAGON LIKE POLYPEPTIDE 1 ON BODY WEIGHT AND BETA-CELL FUNCTION IN OBESE WOMEN WITH POLYCYSTIC OVARIAN SYNDROME

  2018cites this paper
• Health-related functional value of dairy proteins and peptides

  2018cites this paper
• Gastrointestinal Hormones Controlling Energy Homeostasis and Their Potential Role in Obesity

  2018cites this paper
• Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2.

  2018cites this paper
• Metabolic variations in canine overweight Aspects of lipid metabolism in spontaneously overweight Labrador Retriever dogs

  2018cites this paper
• Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant, Pre-diabetic Rats.

  2018cites this paper
• Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index

  2017cites this paper
• Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly

  2017cites this paper
• Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction

  2017cites this paper
• Effects of Anesthesia on Hyperglycemic and Insulinotropic Responses to Intravenous Glucose and Mixed Meal Tolerance Tests in Cynomolgus Monkeys with Naturally Occurring Diabetes

  2017cites this paper
• Effects of small intestinal glucose on glycaemia, insulinaemia and incretin hormone release are load-dependent in obese subjects

  2017cites this paper
• Lifestyle change reduces cardiometabolic risk factors and glucagon‐like peptide‐1 levels in obese first‐degree relatives of people with diabetes

  2017cites this paper
• Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance.

  2017cites this paper
• Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

  2017influential citation
• Glucagon‐like peptide‐1 and glucose‐dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice

  2017cites this paper
• Effects of a high-fat meal on postprandial incretin responses, appetite scores and ad libitum energy intake in women with obesity.

  2017cites this paper
• Alterations in circadian and meal-induced gut peptide levels in lean and obese rats

  2017cites this paper
• DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity

  2017cites this paper
• Regulation of Glucagon-like Peptide-1 Exocytosis from the Primary L-cell by the SNARE Protein Syntaxin-1a

  2017cites this paper
• Up-regulated insulin secretion in insulin resistance mice : Evidence of increased islet GLP-1 receptor expression and GPR 119-activated GLP-1 secretion

  2017cites this paper
• The SNARE Protein Syntaxin-1a Plays an Essential Role in Biphasic Exocytosis of the Incretin Hormone Glucagon-Like Peptide 1

  2017cites this paper
• Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.

  2017cites this paper
• Diabetes Mellitus Tip 2’de İnkretin Temelli Tedaviler

  2017cites this paper
• Intestinal GLP-1 and satiation: from man to rodents and back

  2016cites this paper
• Metabolic and Hormonal Response to a Feed‐challenge Test in Lean and Overweight Dogs

  2016cites this paper
• High-Fat Diet and Palmitate Alter the Rhythmic Secretion of Glucagon-Like Peptide-1 by the Rodent L-cell.

  2016cites this paper
• Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells

  2016cites this paper
• Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36.

  2016cites this paper
• Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors.

  2016cites this paper
• Impaired Glucose Tolerance in Childhood Obesity Contribution of Glucagon , GLP-1 and Inflammation

  2016cites this paper
• The Effects of Acute Consumption and Chronic Supplementation of Cocoa on Overweight and Obese Adults at Risk of Developing Diabetes

  2016cites this paper
• Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats.

  2016cites this paper
• Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9-39] as a GLP-1 Receptor Antagonist

  2016influential citation
• Mechanisms by which cocoa flavanols improve metabolic syndrome and related disorders.

  2016cites this paper
• Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome.

  2016cites this paper
• Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.

  2015cites this paper